The 4 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 3.38, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +164.71% increase from the last price of 1.27.
The current consensus among 4 polled investment analysts is to Buy stock in Vascular Biogenics Ltd. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Aug 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.